TerrAscend (OTCMKTS:TSNDF - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.04, Zacks reports. The firm had revenue of $74.35 million during the quarter, compared to analyst estimates of $72.37 million. TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%.
TerrAscend Trading Up 13.7 %
Shares of OTCMKTS:TSNDF traded up $0.06 during trading on Monday, hitting $0.47. The stock had a trading volume of 862,414 shares, compared to its average volume of 388,003. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. TerrAscend has a 12-month low of $0.38 and a 12-month high of $2.20. The stock has a 50-day simple moving average of $0.57 and a two-hundred day simple moving average of $0.85.
Wall Street Analyst Weigh In
Separately, Atb Cap Markets downgraded shares of TerrAscend from a "strong-buy" rating to a "hold" rating in a research note on Monday, December 9th.
Get Our Latest Stock Analysis on TSNDF
TerrAscend Company Profile
(
Get Free Report)
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
See Also
Before you consider TerrAscend, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.
While TerrAscend currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
